James A Feinstein1, Jonathan Rodean2, Matt Hall2, Stephanie K Doupnik3, James C Gay4, Jessica L Markham5, Jessica L Bettenhausen5, Julia Simmons5, Brigid Garrity6, Jay G Berry6. 1. Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado and Children's Hospital Colorado, Aurora, Colorado; james.feinstein@ucdenver.edu. 2. Children's Hospital Association, Lenexa, Kansas. 3. Division of General Pediatrics, Center for Pediatric Clinical Effectiveness, PolicyLab, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 4. Division of General Pediatrics, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee. 5. Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri; and. 6. Complex Care Service, Division of General Pediatrics, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts.
Abstract
BACKGROUND AND OBJECTIVES: Although potentially dangerous, little is known about outpatient opioid exposure (OE) in children and youth with special health care needs (CYSHCN). We assessed the prevalence and types of OE and the diagnoses and health care encounters proximal to OE in CYSHCN. METHODS: This is a retrospective cohort study of 2 597 987 CYSHCN aged 0-to-18 years from 11 states, continuously enrolled in Medicaid in 2016, with ≥1 chronic condition. OE included any filled prescription (single or multiple) for opioids. Health care encounters were assessed within 7 days before and 7 and 30 days after OE. RESULTS: Among CYSHCN, 7.4% had OE. CYSHCN with OE versus without OE were older (ages 10-18 years: 69.4% vs 47.7%), had more chronic conditions (≥3 conditions: 49.1% vs 30.6%), and had more polypharmacy (≥5 other medication classes: 54.7% vs 31.2%), P < .001 for all. Most (76.7%) OEs were single fills with a median duration of 4 days (interquartile range: 3-6). The most common OEs were acetaminophen-hydrocodone (47.5%), acetaminophen-codeine (21.5%), and oxycodone (9.5%). Emergency department visits preceded 28.8% of OEs, followed by outpatient surgery (28.8%) and outpatient specialty care (19.1%). Most OEs were preceded by a diagnosis of infection (25.9%) or injury (22.3%). Only 35.1% and 62.2% of OEs were associated with follow-up visits within 7 and 30 days, respectively. CONCLUSIONS: OE in CYSHCN is common, especially with multiple chronic conditions and polypharmacy. In subsequent studies, researchers should examine the appropriateness of opioid prescribing, particularly in emergency departments, as well as assess for drug interactions with chronic medications and reasons for insufficient follow-up.
BACKGROUND AND OBJECTIVES: Although potentially dangerous, little is known about outpatient opioid exposure (OE) in children and youth with special health care needs (CYSHCN). We assessed the prevalence and types of OE and the diagnoses and health care encounters proximal to OE in CYSHCN. METHODS: This is a retrospective cohort study of 2 597 987 CYSHCN aged 0-to-18 years from 11 states, continuously enrolled in Medicaid in 2016, with ≥1 chronic condition. OE included any filled prescription (single or multiple) for opioids. Health care encounters were assessed within 7 days before and 7 and 30 days after OE. RESULTS: Among CYSHCN, 7.4% had OE. CYSHCN with OE versus without OE were older (ages 10-18 years: 69.4% vs 47.7%), had more chronic conditions (≥3 conditions: 49.1% vs 30.6%), and had more polypharmacy (≥5 other medication classes: 54.7% vs 31.2%), P < .001 for all. Most (76.7%) OEs were single fills with a median duration of 4 days (interquartile range: 3-6). The most common OEs were acetaminophen-hydrocodone (47.5%), acetaminophen-codeine (21.5%), and oxycodone (9.5%). Emergency department visits preceded 28.8% of OEs, followed by outpatient surgery (28.8%) and outpatient specialty care (19.1%). Most OEs were preceded by a diagnosis of infection (25.9%) or injury (22.3%). Only 35.1% and 62.2% of OEs were associated with follow-up visits within 7 and 30 days, respectively. CONCLUSIONS: OE in CYSHCN is common, especially with multiple chronic conditions and polypharmacy. In subsequent studies, researchers should examine the appropriateness of opioid prescribing, particularly in emergency departments, as well as assess for drug interactions with chronic medications and reasons for insufficient follow-up.
Authors: Rishi Agrawal; Matt Hall; Eyal Cohen; Denise M Goodman; Dennis Z Kuo; John M Neff; Margaret O'Neill; Joanna Thomson; Jay G Berry Journal: Pediatrics Date: 2016-09-15 Impact factor: 7.124
Authors: Calista M Harbaugh; Jay S Lee; Hsou Mei Hu; Sean Esteban McCabe; Terri Voepel-Lewis; Michael J Englesbe; Chad M Brummett; Jennifer F Waljee Journal: Pediatrics Date: 2017-12-04 Impact factor: 7.124
Authors: James A Feinstein; Seth Russell; Peter E DeWitt; Chris Feudtner; Dingwei Dai; Tellen D Bennett Journal: JAMA Pediatr Date: 2018-06-01 Impact factor: 16.193
Authors: Sabrina Gmuca; Rui Xiao; Pamela F Weiss; David D Sherry; Andrea M Knight; Jeffrey S Gerber Journal: Pain Med Date: 2019-03-01 Impact factor: 3.750
Authors: Jay G Berry; Sara L Toomey; Alan M Zaslavsky; Ashish K Jha; Mari M Nakamura; David J Klein; Jeremy Y Feng; Shanna Shulman; Vincent W Chiang; Vincent K Chiang; William Kaplan; Matt Hall; Mark A Schuster Journal: JAMA Date: 2013-01-23 Impact factor: 56.272
Authors: Kelby W Brown; Kayla Carlisle; Sudha R Raman; Peter Shrader; Megan Jiao; Michael J Smith; Lisa M Einhorn; Charlene A Wong Journal: Health Aff (Millwood) Date: 2020-10 Impact factor: 6.301